GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Ltd: Long-term bank facilities rating reaffirmed at CARE A

RATING ▲ Positive Development LOW RISK
📅 Filed on BSE: 02 Sep 2026, 08:55 AM IST  ·  BSE ID: f382ef88-7bc4-4dbd-83eb-a4d4fdb3e4ef
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's creditworthiness for its bank loans has been confirmed, with a stable outlook and increased borrowing capacity.
🤖 AI Summary
  • SMS Pharmaceuticals' long-term bank facilities rating reaffirmed at 'CARE A; Stable'.
  • Amount for long-term facilities enhanced to Rs. 507.07 Crore.
  • Outlook on long-term facilities revised from Positive to Stable.
  • Short-term bank facilities rating reaffirmed at CARE A1.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Long term Bank Facilities Amount
507.07 (Enhanced from 350.87) Rs. Crore
Long term Bank Facilities Rating
CARE A; Stable
Long term Bank Facilities Rating Action
Reaffirmed; Outlook revised from Positive
Short term Bank Facilities Amount
52.83 Rs. Crore
Short term Bank Facilities Rating
CARE A1
Short term Bank Facilities Rating Action
Reaffirmed
🏢 How This Affects the Company
💰
Financial Impact
The enhancement of long-term bank facilities to Rs. 507.07 Crore provides increased financial flexibility for the company's operations and growth initiatives.
⚠️
Risk Impact
The reaffirmation of the 'CARE A; Stable' rating indicates a stable credit profile, suggesting manageable financial risks for the company's ongoing operations.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders. This is a disclosure related to the company's credit rating.
👤
Who Is Affected
All shareholders are indirectly affected as a stable credit rating supports the company's financial operations and stability.
🔍
Management Signal
Management has secured enhanced long-term borrowing capacity with a stable outlook, signaling confidence in the company's financial performance and future prospects.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Company's Q2 FY27 results for operational and financial performance updates.
Subsequent rating reviews by CARE Ratings Limited.
Details on utilization of enhanced bank facilities.
LOW RISK Credit rating reaffirmation and stable outlook indicate sound financial health.
💡 Investor Takeaway
SMS Pharmaceuticals Ltd.'s long-term bank facilities rating is reaffirmed at 'CARE A; Stable' with an enhanced amount of Rs. 507.07 Crore (up from Rs. 350.87 Crore), and short-term facilities at CARE A1.
⚖️ Strengths & Concerns

✅ Positives

  • Long-term bank facilities rating reaffirmed at 'CARE A; Stable' with enhanced amount of Rs. 507.07 Crore.
  • Short-term bank facilities rating reaffirmed at CARE A1, indicating continued strong short-term creditworthiness.
❓ Frequently Asked Questions
What is SMS Pharmaceuticals Ltd.'s credit rating for its long-term bank facilities?
SMS Pharmaceuticals Ltd.'s long-term bank facilities rating has been reaffirmed at 'CARE A; Stable' by CARE Ratings Limited.
What is the updated amount for SMS Pharmaceuticals Ltd.'s long-term bank facilities?
The amount for the long-term bank facilities has been enhanced to Rs. 507.07 Crore, an increase from Rs. 350.87 Crore.
What is the credit rating for SMS Pharmaceuticals Ltd.'s short-term bank facilities?
The credit rating for SMS Pharmaceuticals Ltd.'s short-term bank facilities has been reaffirmed at CARE A1.
What was the previous outlook on SMS Pharmaceuticals Ltd.'s long-term bank facilities?
The outlook on SMS Pharmaceuticals Ltd.'s long-term bank facilities was previously 'Positive' and has now been revised to 'Stable'.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.